MedTrace Logo

Sodium Intake in Multiple Sclerosis

NCT01846234 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 132

Last updated 2013-10-22

No results posted yet for this study

Summary

Recently, it has been shown that salt (ClNa, sodium chloride) can modulate the differentiation of human and mouse TH17 cells. Indeed, mice feed with high sodium diet were described to develop more aggressive course of EAE (Experimental Autoimmune Encephalitis).

However, the role of sodium intake in MS has not been investigated. In this study we investigate the effect of sodium intake in Multiple Sclerosis (MS) clinical and radiological activity.

Conditions

Sponsors & Collaborators

  • Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia

    lead OTHER

Principal Investigators

  • Mauricio F Farez, MD MPH · Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2013-07-31
Completion
2013-07-31

Countries

  • Argentina

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01846234 on ClinicalTrials.gov